Nevro (NVRO)
(Real Time Quote from BATS)
$5.68 USD
-0.17 (-2.91%)
Updated Sep 20, 2024 11:24 AM ET
3-Hold of 5 3
F Value B Growth F Momentum D VGM
Balance Sheet
Fiscal Year End for Nevro Corp falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 323 | 374 | 362 | 588 | 238 |
Receivables | 79 | 79 | 70 | 78 | 83 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 119 | 100 | 94 | 83 | 92 |
Other Current Assets | 10 | 10 | 5 | 4 | 10 |
Total Current Assets | 531 | 563 | 531 | 753 | 422 |
Net Property & Equipment | 25 | 22 | 21 | 14 | 12 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 66 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 6 | 4 | 5 | 5 | 14 |
Total Assets | 636 | 602 | 575 | 789 | 470 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 23 | 27 | 32 | 23 | 16 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 169 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 45 | 47 | 46 | 43 | 51 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 16 | 5 | 5 | 4 | 4 |
Total Current Liabilities | 83 | 79 | 82 | 239 | 71 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 211 | 187 | 151 | 142 | 160 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 43 | 2 | 22 | 3 | 2 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 343 | 279 | 271 | 401 | 253 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 993 | 934 | 928 | 881 | 626 |
Retained Earnings | -699 | -607 | -624 | -493 | -410 |
Other Equity | 0 | -3 | 0 | 1 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 293 | 324 | 304 | 388 | 216 |
Total Liabilities & Shareholder's Equity | 636 | 602 | 575 | 789 | 470 |
Total Common Equity | 293 | 324 | 304 | 388 | 216 |
Shares Outstanding | 36.20 | 35.40 | 34.90 | 34.40 | 31.00 |
Book Value Per Share | 8.10 | 9.15 | 8.70 | 11.29 | 6.98 |
Fiscal Year End for Nevro Corp falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 274 | 281 | 323 | 320 | 330 |
Receivables | 74 | 77 | 79 | 69 | 69 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 126 | 121 | 119 | 122 | 120 |
Other Current Assets | 12 | 13 | 10 | 10 | 12 |
Total Current Assets | 486 | 493 | 531 | 522 | 531 |
Net Property & Equipment | 25 | 25 | 25 | 24 | 24 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 64 | 65 | 66 | 0 | 0 |
Deposits & Other Assets | 6 | 6 | 6 | 5 | 3 |
Total Assets | 603 | 596 | 636 | 562 | 570 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 23 | 21 | 23 | 29 | 30 |
Current Portion Long-Term Debt | 38 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 39 | 39 | 45 | 45 | 42 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 2 | 6 | 16 | 6 | 5 |
Total Current Liabilities | 102 | 67 | 83 | 80 | 78 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 181 | 215 | 211 | 188 | 187 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 23 | 43 | 2 | 2 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 329 | 318 | 343 | 276 | 275 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 1,020 | 1,004 | 993 | 978 | 964 |
Retained Earnings | -744 | -725 | -699 | -690 | -667 |
Other Equity | -1 | -1 | 0 | -2 | -2 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 274 | 279 | 293 | 286 | 295 |
Total Liabilities & Shareholder's Equity | 603 | 596 | 636 | 562 | 570 |
Total Common Equity | 274 | 279 | 293 | 286 | 295 |
Shares Outstanding | 36.70 | 36.60 | 36.20 | 36.20 | 36.10 |
Book Value Per Share | 7.47 | 7.61 | 8.10 | 7.89 | 8.16 |